Screening before prolonged immunosuppressive therapy: Difference between revisions
From IDWiki
m (Aidan moved page Special Immune Infectious disease screening for prolonged immunosuppressive therapy to Screening before prolonged immunosuppressive therapy without leaving a redirect) |
No edit summary |
||
| Line 1: | Line 1: | ||
| − | = ID screening for prolonged immunosuppressive therapy = |
||
| − | |||
* Tuberculosis |
* Tuberculosis |
||
** Screen if pred 15mg daily for 1+ month |
** Screen if pred 15mg daily for 1+ month |
||
| Line 12: | Line 10: | ||
* Strongyloides |
* Strongyloides |
||
** Screen with serology if has ever travelled to an endemic country |
** Screen with serology if has ever travelled to an endemic country |
||
| + | |||
| + | [[Category:Immunocompromised patients]] |
||
Revision as of 21:31, 15 August 2019
- Tuberculosis
- Screen if pred 15mg daily for 1+ month
- TB skin test (false positive if BCG and needs a 48h repeat)
- Still useful to test up after up to two weeks of ≤20mg daily prednisone
- IGRA (expensive)
- Hepatitis B
- Screen if >7.5mg prednisone daily
- Treat if HbSag positive or if HbCAb and HBV-DNA positive
- Prophylaxis with lemivudine for 6 months after the immune suppression is done
- Strongyloides
- Screen with serology if has ever travelled to an endemic country
